Loading clinical trials...
Loading clinical trials...
Pure-Heart-1: A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
Conditions
Locations
1
United States
Boston Children's Hospital
Boston, Massachusetts, United States
Start Date
January 1, 2014
Primary Completion Date
August 1, 2019
Completion Date
December 1, 2020
Last Updated
March 3, 2021
NCT04770012
NCT05826444
NCT05756088
NCT04791852
NCT02013037
NCT03808324
Lead Sponsor
Boston Children's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions